Biopharmaceutical Excipients Market Analysis of Innovation and Commercial Potential
The biopharmaceutical excipients market is experiencing a transformative phase, projected to reach a remarkable USD 12.4 billion by 2035, growing from USD 7.18 billion in 2024. This substantial uptick reflects a compound annual growth rate (CAGR) of 5.09%. The rising demand for biopharmaceuticals, particularly in injectable and oral formulations, is a key driver of this expansion. With North...
0 Commentarii 0 Distribuiri 2 Views 0 previzualizare